nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP3A5—prostate cancer	0.158	0.698	CbGaD
Eplerenone—Testosterone—Abiraterone—prostate cancer	0.101	0.3	CrCrCtD
Eplerenone—CYP3A4—prostate cancer	0.0686	0.302	CbGaD
Eplerenone—Testosterone Propionate—Estradiol valerate/Dienogest—prostate cancer	0.057	0.169	CrCrCtD
Eplerenone—Testosterone—Estramustine—prostate cancer	0.0421	0.124	CrCrCtD
Eplerenone—Testosterone—Estrone—prostate cancer	0.0334	0.0988	CrCrCtD
Eplerenone—Methyltestosterone—Ethinyl Estradiol—prostate cancer	0.0278	0.0821	CrCrCtD
Eplerenone—CYP3A5—Flutamide—prostate cancer	0.026	0.105	CbGbCtD
Eplerenone—Testosterone—Estradiol—prostate cancer	0.0253	0.0749	CrCrCtD
Eplerenone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0233	0.0943	CbGbCtD
Eplerenone—CYP3A5—Cabazitaxel—prostate cancer	0.0192	0.0778	CbGbCtD
Eplerenone—CYP3A5—Estrone—prostate cancer	0.0188	0.0761	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0144	0.0583	CbGbCtD
Eplerenone—CYP3A7—Estradiol—prostate cancer	0.0144	0.0583	CbGbCtD
Eplerenone—CYP3A4—Bicalutamide—prostate cancer	0.0122	0.0495	CbGbCtD
Eplerenone—Hydrocortamate—Prednisone—prostate cancer	0.0119	0.0351	CrCrCtD
Eplerenone—Cortisone acetate—Prednisone—prostate cancer	0.0115	0.0341	CrCrCtD
Eplerenone—CYP3A4—Estramustine—prostate cancer	0.0114	0.046	CbGbCtD
Eplerenone—CYP3A5—Estradiol—prostate cancer	0.0108	0.0437	CbGbCtD
Eplerenone—CYP3A4—Flutamide—prostate cancer	0.0101	0.041	CbGbCtD
Eplerenone—CYP3A4—Abiraterone—prostate cancer	0.0101	0.041	CbGbCtD
Eplerenone—Fludrocortisone—Prednisone—prostate cancer	0.01	0.0296	CrCrCtD
Eplerenone—Methyltestosterone—Prednisone—prostate cancer	0.00975	0.0288	CrCrCtD
Eplerenone—CYP3A7—Docetaxel—prostate cancer	0.00859	0.0348	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00859	0.0348	CbGbCtD
Eplerenone—Hydrocortisone—Prednisone—prostate cancer	0.00816	0.0241	CrCrCtD
Eplerenone—CYP3A4—Cabazitaxel—prostate cancer	0.00749	0.0304	CbGbCtD
Eplerenone—CYP3A4—Estrone—prostate cancer	0.00732	0.0297	CbGbCtD
Eplerenone—CYP3A5—Etoposide—prostate cancer	0.00704	0.0285	CbGbCtD
Eplerenone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00653	0.0264	CbGbCtD
Eplerenone—CYP3A5—Docetaxel—prostate cancer	0.00644	0.0261	CbGbCtD
Eplerenone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00479	0.0194	CbGbCtD
Eplerenone—CYP3A4—Mitoxantrone—prostate cancer	0.00436	0.0176	CbGbCtD
Eplerenone—CYP3A4—Estradiol—prostate cancer	0.00421	0.017	CbGbCtD
Eplerenone—CYP3A4—Prednisone—prostate cancer	0.00362	0.0147	CbGbCtD
Eplerenone—CYP3A4—Etoposide—prostate cancer	0.00275	0.0111	CbGbCtD
Eplerenone—CYP3A4—Docetaxel—prostate cancer	0.00251	0.0102	CbGbCtD
Eplerenone—CYP3A4—Doxorubicin—prostate cancer	0.00187	0.00759	CbGbCtD
Eplerenone—CYP11B2—renal system—prostate cancer	0.00047	0.181	CbGeAlD
Eplerenone—CYP3A4—urine—prostate cancer	0.000344	0.132	CbGeAlD
Eplerenone—NR3C2—prostate gland—prostate cancer	0.000305	0.117	CbGeAlD
Eplerenone—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	0.000272	0.0757	CrCbGaD
Eplerenone—NR3C2—seminal vesicle—prostate cancer	0.000258	0.099	CbGeAlD
Eplerenone—CYP11B2—lymph node—prostate cancer	0.00022	0.0847	CbGeAlD
Eplerenone—NR3C2—renal system—prostate cancer	0.000208	0.0798	CbGeAlD
Eplerenone—NR3C2—urethra—prostate cancer	0.000204	0.0784	CbGeAlD
Eplerenone—CYP3A5—prostate gland—prostate cancer	0.000165	0.0633	CbGeAlD
Eplerenone—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	0.000151	0.0419	CrCbGaD
Eplerenone—Testosterone Propionate—CYP17A1—prostate cancer	0.000142	0.0395	CrCbGaD
Eplerenone—Hydrocortisone—ANXA1—prostate cancer	0.000139	0.0388	CrCbGaD
Eplerenone—Testosterone—CYP3A43—prostate cancer	0.000136	0.0378	CrCbGaD
Eplerenone—NR3C2—testis—prostate cancer	0.000134	0.0516	CbGeAlD
Eplerenone—Testosterone Propionate—COMT—prostate cancer	0.000116	0.0322	CrCbGaD
Eplerenone—CYP3A5—renal system—prostate cancer	0.000112	0.0431	CbGeAlD
Eplerenone—Drospirenone—AR—prostate cancer	0.000103	0.0286	CrCbGaD
Eplerenone—NR3C2—lymph node—prostate cancer	9.73e-05	0.0374	CbGeAlD
Eplerenone—Fludrocortisone—AR—prostate cancer	9.69e-05	0.027	CrCbGaD
Eplerenone—Fluoxymesterone—SHBG—prostate cancer	9.13e-05	0.0254	CrCbGaD
Eplerenone—Testosterone Propionate—AR—prostate cancer	8.64e-05	0.024	CrCbGaD
Eplerenone—Hydrocortamate—NR3C1—prostate cancer	8.42e-05	0.0234	CrCbGaD
Eplerenone—CYP3A4—renal system—prostate cancer	8.42e-05	0.0324	CbGeAlD
Eplerenone—Spironolactone—SHBG—prostate cancer	8.36e-05	0.0232	CrCbGaD
Eplerenone—Cortisone acetate—NR3C1—prostate cancer	8.29e-05	0.0231	CrCbGaD
Eplerenone—Fluoxymesterone—AR—prostate cancer	8e-05	0.0223	CrCbGaD
Eplerenone—Medroxyprogesterone Acetate—SHBG—prostate cancer	7.83e-05	0.0218	CrCbGaD
Eplerenone—Methyltestosterone—SHBG—prostate cancer	7.37e-05	0.0205	CrCbGaD
Eplerenone—Spironolactone—AR—prostate cancer	7.33e-05	0.0204	CrCbGaD
Eplerenone—Medroxyprogesterone Acetate—AR—prostate cancer	6.87e-05	0.0191	CrCbGaD
Eplerenone—Fludrocortisone—NR3C1—prostate cancer	6.57e-05	0.0183	CrCbGaD
Eplerenone—Progesterone—CYP17A1—prostate cancer	6.52e-05	0.0182	CrCbGaD
Eplerenone—Methyltestosterone—AR—prostate cancer	6.46e-05	0.018	CrCbGaD
Eplerenone—Progesterone—SLC22A3—prostate cancer	6.22e-05	0.0173	CrCbGaD
Eplerenone—Fluoxymesterone—ESR1—prostate cancer	6.17e-05	0.0172	CrCbGaD
Eplerenone—Testosterone—SLC22A3—prostate cancer	5.88e-05	0.0164	CrCbGaD
Eplerenone—Hydrocortisone—SHBG—prostate cancer	5.55e-05	0.0154	CrCbGaD
Eplerenone—Fluoxymesterone—NR3C1—prostate cancer	5.43e-05	0.0151	CrCbGaD
Eplerenone—Methyltestosterone—CYP19A1—prostate cancer	5.41e-05	0.0151	CrCbGaD
Eplerenone—Medroxyprogesterone Acetate—ESR1—prostate cancer	5.29e-05	0.0147	CrCbGaD
Eplerenone—Spironolactone—NR3C1—prostate cancer	4.97e-05	0.0138	CrCbGaD
Eplerenone—Hydrocortamate—CYP3A4—prostate cancer	4.88e-05	0.0136	CrCbGaD
Eplerenone—Cortisone acetate—CYP3A4—prostate cancer	4.81e-05	0.0134	CrCbGaD
Eplerenone—Medroxyprogesterone Acetate—NR3C1—prostate cancer	4.66e-05	0.013	CrCbGaD
Eplerenone—Progesterone—SHBG—prostate cancer	4.52e-05	0.0126	CrCbGaD
Eplerenone—Progesterone—CYP1B1—prostate cancer	4.52e-05	0.0126	CrCbGaD
Eplerenone—Progesterone—SLC22A1—prostate cancer	4.46e-05	0.0124	CrCbGaD
Eplerenone—Hydrocortisone—CYP3A5—prostate cancer	4.42e-05	0.0123	CrCbGaD
Eplerenone—Testosterone—CYP1B1—prostate cancer	4.28e-05	0.0119	CrCbGaD
Eplerenone—Testosterone—SHBG—prostate cancer	4.28e-05	0.0119	CrCbGaD
Eplerenone—Testosterone—SLC22A1—prostate cancer	4.22e-05	0.0117	CrCbGaD
Eplerenone—Progesterone—AR—prostate cancer	3.97e-05	0.011	CrCbGaD
Eplerenone—Drospirenone—PTGS2—prostate cancer	3.96e-05	0.011	CrCbGaD
Eplerenone—Testosterone—AR—prostate cancer	3.75e-05	0.0104	CrCbGaD
Eplerenone—Progesterone—CYP3A5—prostate cancer	3.6e-05	0.01	CrCbGaD
Eplerenone—Chest pain—Docetaxel—prostate cancer	3.6e-05	0.000321	CcSEcCtD
Eplerenone—Myalgia—Docetaxel—prostate cancer	3.6e-05	0.000321	CcSEcCtD
Eplerenone—Arthralgia—Docetaxel—prostate cancer	3.6e-05	0.000321	CcSEcCtD
Eplerenone—Loss of consciousness—Capecitabine—prostate cancer	3.6e-05	0.000321	CcSEcCtD
Eplerenone—Renal failure—Epirubicin—prostate cancer	3.59e-05	0.00032	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Etoposide—prostate cancer	3.58e-05	0.00032	CcSEcCtD
Eplerenone—Asthenia—Mitoxantrone—prostate cancer	3.58e-05	0.000319	CcSEcCtD
Eplerenone—Fatigue—Etoposide—prostate cancer	3.58e-05	0.000319	CcSEcCtD
Eplerenone—Neuropathy peripheral—Epirubicin—prostate cancer	3.58e-05	0.000319	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	3.57e-05	0.000319	CcSEcCtD
Eplerenone—Cough—Capecitabine—prostate cancer	3.57e-05	0.000319	CcSEcCtD
Eplerenone—Pain—Etoposide—prostate cancer	3.55e-05	0.000317	CcSEcCtD
Eplerenone—Constipation—Etoposide—prostate cancer	3.55e-05	0.000317	CcSEcCtD
Eplerenone—Urinary tract infection—Epirubicin—prostate cancer	3.55e-05	0.000316	CcSEcCtD
Eplerenone—Dizziness—Estradiol—prostate cancer	3.54e-05	0.000316	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Doxorubicin—prostate cancer	3.52e-05	0.000314	CcSEcCtD
Eplerenone—Progesterone—CYP2A6—prostate cancer	3.49e-05	0.0097	CrCbGaD
Eplerenone—Chest pain—Capecitabine—prostate cancer	3.48e-05	0.000311	CcSEcCtD
Eplerenone—Arthralgia—Capecitabine—prostate cancer	3.48e-05	0.000311	CcSEcCtD
Eplerenone—Myalgia—Capecitabine—prostate cancer	3.48e-05	0.000311	CcSEcCtD
Eplerenone—Haematuria—Epirubicin—prostate cancer	3.48e-05	0.00031	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	3.46e-05	0.000309	CcSEcCtD
Eplerenone—Hepatobiliary disease—Epirubicin—prostate cancer	3.45e-05	0.000308	CcSEcCtD
Eplerenone—Discomfort—Capecitabine—prostate cancer	3.44e-05	0.000307	CcSEcCtD
Eplerenone—Infection—Docetaxel—prostate cancer	3.43e-05	0.000306	CcSEcCtD
Eplerenone—Feeling abnormal—Etoposide—prostate cancer	3.42e-05	0.000305	CcSEcCtD
Eplerenone—Hyperglycaemia—Doxorubicin—prostate cancer	3.42e-05	0.000305	CcSEcCtD
Eplerenone—Diarrhoea—Mitoxantrone—prostate cancer	3.41e-05	0.000305	CcSEcCtD
Eplerenone—Vomiting—Estradiol—prostate cancer	3.41e-05	0.000304	CcSEcCtD
Eplerenone—Testosterone—CYP3A5—prostate cancer	3.4e-05	0.00947	CrCbGaD
Eplerenone—Pneumonia—Doxorubicin—prostate cancer	3.4e-05	0.000303	CcSEcCtD
Eplerenone—Gastrointestinal pain—Etoposide—prostate cancer	3.39e-05	0.000303	CcSEcCtD
Eplerenone—Shock—Docetaxel—prostate cancer	3.39e-05	0.000303	CcSEcCtD
Eplerenone—Nervous system disorder—Docetaxel—prostate cancer	3.38e-05	0.000302	CcSEcCtD
Eplerenone—Ill-defined disorder—Prednisone—prostate cancer	3.38e-05	0.000302	CcSEcCtD
Eplerenone—Rash—Estradiol—prostate cancer	3.38e-05	0.000301	CcSEcCtD
Eplerenone—Infestation—Doxorubicin—prostate cancer	3.38e-05	0.000301	CcSEcCtD
Eplerenone—Infestation NOS—Doxorubicin—prostate cancer	3.38e-05	0.000301	CcSEcCtD
Eplerenone—Dermatitis—Estradiol—prostate cancer	3.37e-05	0.000301	CcSEcCtD
Eplerenone—Anaemia—Prednisone—prostate cancer	3.37e-05	0.000301	CcSEcCtD
Eplerenone—Headache—Estradiol—prostate cancer	3.36e-05	0.000299	CcSEcCtD
Eplerenone—Skin disorder—Docetaxel—prostate cancer	3.35e-05	0.000299	CcSEcCtD
Eplerenone—Angioedema—Prednisone—prostate cancer	3.33e-05	0.000297	CcSEcCtD
Eplerenone—Renal failure—Doxorubicin—prostate cancer	3.32e-05	0.000296	CcSEcCtD
Eplerenone—Infection—Capecitabine—prostate cancer	3.32e-05	0.000296	CcSEcCtD
Eplerenone—Neuropathy peripheral—Doxorubicin—prostate cancer	3.31e-05	0.000295	CcSEcCtD
Eplerenone—Hydrocortisone—NR3C1—prostate cancer	3.3e-05	0.00918	CrCbGaD
Eplerenone—Malaise—Prednisone—prostate cancer	3.29e-05	0.000293	CcSEcCtD
Eplerenone—Shock—Capecitabine—prostate cancer	3.29e-05	0.000293	CcSEcCtD
Eplerenone—Abdominal pain—Etoposide—prostate cancer	3.28e-05	0.000293	CcSEcCtD
Eplerenone—Body temperature increased—Etoposide—prostate cancer	3.28e-05	0.000293	CcSEcCtD
Eplerenone—Urinary tract infection—Doxorubicin—prostate cancer	3.28e-05	0.000293	CcSEcCtD
Eplerenone—Nervous system disorder—Capecitabine—prostate cancer	3.28e-05	0.000292	CcSEcCtD
Eplerenone—Syncope—Prednisone—prostate cancer	3.27e-05	0.000292	CcSEcCtD
Eplerenone—Hypoaesthesia—Epirubicin—prostate cancer	3.26e-05	0.000291	CcSEcCtD
Eplerenone—Pharyngitis—Epirubicin—prostate cancer	3.25e-05	0.00029	CcSEcCtD
Eplerenone—Skin disorder—Capecitabine—prostate cancer	3.24e-05	0.000289	CcSEcCtD
Eplerenone—Urinary tract disorder—Epirubicin—prostate cancer	3.23e-05	0.000289	CcSEcCtD
Eplerenone—Hyperhidrosis—Capecitabine—prostate cancer	3.23e-05	0.000288	CcSEcCtD
Eplerenone—Oedema peripheral—Epirubicin—prostate cancer	3.23e-05	0.000288	CcSEcCtD
Eplerenone—Hypotension—Docetaxel—prostate cancer	3.22e-05	0.000288	CcSEcCtD
Eplerenone—Haematuria—Doxorubicin—prostate cancer	3.22e-05	0.000287	CcSEcCtD
Eplerenone—Connective tissue disorder—Epirubicin—prostate cancer	3.22e-05	0.000287	CcSEcCtD
Eplerenone—Urethral disorder—Epirubicin—prostate cancer	3.21e-05	0.000286	CcSEcCtD
Eplerenone—Loss of consciousness—Prednisone—prostate cancer	3.2e-05	0.000286	CcSEcCtD
Eplerenone—Hepatobiliary disease—Doxorubicin—prostate cancer	3.19e-05	0.000285	CcSEcCtD
Eplerenone—Nausea—Estradiol—prostate cancer	3.18e-05	0.000284	CcSEcCtD
Eplerenone—Vomiting—Mitoxantrone—prostate cancer	3.17e-05	0.000283	CcSEcCtD
Eplerenone—Rash—Mitoxantrone—prostate cancer	3.15e-05	0.000281	CcSEcCtD
Eplerenone—Dermatitis—Mitoxantrone—prostate cancer	3.14e-05	0.00028	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.14e-05	0.00028	CcSEcCtD
Eplerenone—Testosterone—CYP19A1—prostate cancer	3.14e-05	0.00873	CrCbGaD
Eplerenone—Headache—Mitoxantrone—prostate cancer	3.13e-05	0.000279	CcSEcCtD
Eplerenone—Hypotension—Capecitabine—prostate cancer	3.12e-05	0.000278	CcSEcCtD
Eplerenone—Insomnia—Docetaxel—prostate cancer	3.12e-05	0.000278	CcSEcCtD
Eplerenone—Arthralgia—Prednisone—prostate cancer	3.1e-05	0.000277	CcSEcCtD
Eplerenone—Myalgia—Prednisone—prostate cancer	3.1e-05	0.000277	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.08e-05	0.000275	CcSEcCtD
Eplerenone—Dyspnoea—Docetaxel—prostate cancer	3.08e-05	0.000274	CcSEcCtD
Eplerenone—Discomfort—Prednisone—prostate cancer	3.07e-05	0.000274	CcSEcCtD
Eplerenone—Progesterone—ESR1—prostate cancer	3.05e-05	0.0085	CrCbGaD
Eplerenone—Tinnitus—Epirubicin—prostate cancer	3.05e-05	0.000272	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.04e-05	0.000271	CcSEcCtD
Eplerenone—Cardiac disorder—Epirubicin—prostate cancer	3.04e-05	0.000271	CcSEcCtD
Eplerenone—Flushing—Epirubicin—prostate cancer	3.04e-05	0.000271	CcSEcCtD
Eplerenone—Dyspepsia—Docetaxel—prostate cancer	3.04e-05	0.000271	CcSEcCtD
Eplerenone—Insomnia—Capecitabine—prostate cancer	3.02e-05	0.00027	CcSEcCtD
Eplerenone—Hypoaesthesia—Doxorubicin—prostate cancer	3.02e-05	0.000269	CcSEcCtD
Eplerenone—Pharyngitis—Doxorubicin—prostate cancer	3.01e-05	0.000268	CcSEcCtD
Eplerenone—Urinary tract disorder—Doxorubicin—prostate cancer	2.99e-05	0.000267	CcSEcCtD
Eplerenone—Oedema peripheral—Doxorubicin—prostate cancer	2.99e-05	0.000266	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Docetaxel—prostate cancer	2.98e-05	0.000266	CcSEcCtD
Eplerenone—Asthenia—Etoposide—prostate cancer	2.98e-05	0.000266	CcSEcCtD
Eplerenone—Connective tissue disorder—Doxorubicin—prostate cancer	2.98e-05	0.000266	CcSEcCtD
Eplerenone—Dyspnoea—Capecitabine—prostate cancer	2.98e-05	0.000266	CcSEcCtD
Eplerenone—Fatigue—Docetaxel—prostate cancer	2.97e-05	0.000265	CcSEcCtD
Eplerenone—Angiopathy—Epirubicin—prostate cancer	2.97e-05	0.000265	CcSEcCtD
Eplerenone—Urethral disorder—Doxorubicin—prostate cancer	2.97e-05	0.000265	CcSEcCtD
Eplerenone—Nausea—Mitoxantrone—prostate cancer	2.96e-05	0.000264	CcSEcCtD
Eplerenone—Infection—Prednisone—prostate cancer	2.96e-05	0.000264	CcSEcCtD
Eplerenone—Mediastinal disorder—Epirubicin—prostate cancer	2.95e-05	0.000263	CcSEcCtD
Eplerenone—Constipation—Docetaxel—prostate cancer	2.95e-05	0.000263	CcSEcCtD
Eplerenone—Pain—Docetaxel—prostate cancer	2.95e-05	0.000263	CcSEcCtD
Eplerenone—Dyspepsia—Capecitabine—prostate cancer	2.94e-05	0.000262	CcSEcCtD
Eplerenone—Pruritus—Etoposide—prostate cancer	2.94e-05	0.000262	CcSEcCtD
Eplerenone—Shock—Prednisone—prostate cancer	2.93e-05	0.000261	CcSEcCtD
Eplerenone—Nervous system disorder—Prednisone—prostate cancer	2.92e-05	0.00026	CcSEcCtD
Eplerenone—Skin disorder—Prednisone—prostate cancer	2.89e-05	0.000258	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Capecitabine—prostate cancer	2.88e-05	0.000257	CcSEcCtD
Eplerenone—Fatigue—Capecitabine—prostate cancer	2.88e-05	0.000257	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisone—prostate cancer	2.88e-05	0.000257	CcSEcCtD
Eplerenone—Mental disorder—Epirubicin—prostate cancer	2.87e-05	0.000256	CcSEcCtD
Eplerenone—Pain—Capecitabine—prostate cancer	2.86e-05	0.000255	CcSEcCtD
Eplerenone—Constipation—Capecitabine—prostate cancer	2.86e-05	0.000255	CcSEcCtD
Eplerenone—Malnutrition—Epirubicin—prostate cancer	2.85e-05	0.000254	CcSEcCtD
Eplerenone—Feeling abnormal—Docetaxel—prostate cancer	2.84e-05	0.000254	CcSEcCtD
Eplerenone—Diarrhoea—Etoposide—prostate cancer	2.84e-05	0.000253	CcSEcCtD
Eplerenone—Tinnitus—Doxorubicin—prostate cancer	2.83e-05	0.000252	CcSEcCtD
Eplerenone—Gastrointestinal pain—Docetaxel—prostate cancer	2.82e-05	0.000252	CcSEcCtD
Eplerenone—Cardiac disorder—Doxorubicin—prostate cancer	2.81e-05	0.000251	CcSEcCtD
Eplerenone—Flushing—Doxorubicin—prostate cancer	2.81e-05	0.000251	CcSEcCtD
Eplerenone—Flatulence—Epirubicin—prostate cancer	2.81e-05	0.000251	CcSEcCtD
Eplerenone—Back pain—Epirubicin—prostate cancer	2.76e-05	0.000246	CcSEcCtD
Eplerenone—Feeling abnormal—Capecitabine—prostate cancer	2.75e-05	0.000246	CcSEcCtD
Eplerenone—Angiopathy—Doxorubicin—prostate cancer	2.75e-05	0.000245	CcSEcCtD
Eplerenone—Dizziness—Etoposide—prostate cancer	2.75e-05	0.000245	CcSEcCtD
Eplerenone—Muscle spasms—Epirubicin—prostate cancer	2.74e-05	0.000245	CcSEcCtD
Eplerenone—Gastrointestinal pain—Capecitabine—prostate cancer	2.73e-05	0.000244	CcSEcCtD
Eplerenone—Mediastinal disorder—Doxorubicin—prostate cancer	2.73e-05	0.000244	CcSEcCtD
Eplerenone—Body temperature increased—Docetaxel—prostate cancer	2.73e-05	0.000243	CcSEcCtD
Eplerenone—Abdominal pain—Docetaxel—prostate cancer	2.73e-05	0.000243	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Prednisone—prostate cancer	2.71e-05	0.000242	CcSEcCtD
Eplerenone—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	2.7e-05	0.00751	CrCbGaD
Eplerenone—Insomnia—Prednisone—prostate cancer	2.69e-05	0.00024	CcSEcCtD
Eplerenone—Progesterone—NR3C1—prostate cancer	2.69e-05	0.00748	CrCbGaD
Eplerenone—Mental disorder—Doxorubicin—prostate cancer	2.66e-05	0.000237	CcSEcCtD
Eplerenone—Ill-defined disorder—Epirubicin—prostate cancer	2.65e-05	0.000236	CcSEcCtD
Eplerenone—Abdominal pain—Capecitabine—prostate cancer	2.64e-05	0.000236	CcSEcCtD
Eplerenone—Body temperature increased—Capecitabine—prostate cancer	2.64e-05	0.000236	CcSEcCtD
Eplerenone—Vomiting—Etoposide—prostate cancer	2.64e-05	0.000235	CcSEcCtD
Eplerenone—Malnutrition—Doxorubicin—prostate cancer	2.64e-05	0.000235	CcSEcCtD
Eplerenone—Anaemia—Epirubicin—prostate cancer	2.64e-05	0.000235	CcSEcCtD
Eplerenone—Dyspepsia—Prednisone—prostate cancer	2.62e-05	0.000234	CcSEcCtD
Eplerenone—Rash—Etoposide—prostate cancer	2.62e-05	0.000234	CcSEcCtD
Eplerenone—Dermatitis—Etoposide—prostate cancer	2.62e-05	0.000233	CcSEcCtD
Eplerenone—Headache—Etoposide—prostate cancer	2.6e-05	0.000232	CcSEcCtD
Eplerenone—Flatulence—Doxorubicin—prostate cancer	2.6e-05	0.000232	CcSEcCtD
Eplerenone—Malaise—Epirubicin—prostate cancer	2.57e-05	0.000229	CcSEcCtD
Eplerenone—Fatigue—Prednisone—prostate cancer	2.57e-05	0.000229	CcSEcCtD
Eplerenone—Syncope—Epirubicin—prostate cancer	2.56e-05	0.000228	CcSEcCtD
Eplerenone—Back pain—Doxorubicin—prostate cancer	2.55e-05	0.000228	CcSEcCtD
Eplerenone—Constipation—Prednisone—prostate cancer	2.54e-05	0.000227	CcSEcCtD
Eplerenone—Methyltestosterone—CYP3A4—prostate cancer	2.54e-05	0.00707	CrCbGaD
Eplerenone—Muscle spasms—Doxorubicin—prostate cancer	2.54e-05	0.000226	CcSEcCtD
Eplerenone—Loss of consciousness—Epirubicin—prostate cancer	2.51e-05	0.000224	CcSEcCtD
Eplerenone—Cough—Epirubicin—prostate cancer	2.49e-05	0.000222	CcSEcCtD
Eplerenone—Asthenia—Docetaxel—prostate cancer	2.48e-05	0.000221	CcSEcCtD
Eplerenone—Nausea—Etoposide—prostate cancer	2.47e-05	0.00022	CcSEcCtD
Eplerenone—Feeling abnormal—Prednisone—prostate cancer	2.45e-05	0.000219	CcSEcCtD
Eplerenone—Progesterone—CYP2C19—prostate cancer	2.45e-05	0.00682	CrCbGaD
Eplerenone—Ill-defined disorder—Doxorubicin—prostate cancer	2.45e-05	0.000218	CcSEcCtD
Eplerenone—Progesterone—CYP1A1—prostate cancer	2.44e-05	0.00679	CrCbGaD
Eplerenone—Pruritus—Docetaxel—prostate cancer	2.44e-05	0.000218	CcSEcCtD
Eplerenone—Anaemia—Doxorubicin—prostate cancer	2.44e-05	0.000218	CcSEcCtD
Eplerenone—Gastrointestinal pain—Prednisone—prostate cancer	2.43e-05	0.000217	CcSEcCtD
Eplerenone—Myalgia—Epirubicin—prostate cancer	2.43e-05	0.000217	CcSEcCtD
Eplerenone—Chest pain—Epirubicin—prostate cancer	2.43e-05	0.000217	CcSEcCtD
Eplerenone—Arthralgia—Epirubicin—prostate cancer	2.43e-05	0.000217	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.41e-05	0.000215	CcSEcCtD
Eplerenone—Discomfort—Epirubicin—prostate cancer	2.4e-05	0.000214	CcSEcCtD
Eplerenone—Asthenia—Capecitabine—prostate cancer	2.4e-05	0.000214	CcSEcCtD
Eplerenone—Malaise—Doxorubicin—prostate cancer	2.38e-05	0.000212	CcSEcCtD
Eplerenone—Syncope—Doxorubicin—prostate cancer	2.37e-05	0.000211	CcSEcCtD
Eplerenone—Pruritus—Capecitabine—prostate cancer	2.36e-05	0.000211	CcSEcCtD
Eplerenone—Diarrhoea—Docetaxel—prostate cancer	2.36e-05	0.000211	CcSEcCtD
Eplerenone—Body temperature increased—Prednisone—prostate cancer	2.35e-05	0.00021	CcSEcCtD
Eplerenone—Abdominal pain—Prednisone—prostate cancer	2.35e-05	0.00021	CcSEcCtD
Eplerenone—Loss of consciousness—Doxorubicin—prostate cancer	2.32e-05	0.000207	CcSEcCtD
Eplerenone—Testosterone—CYP2C19—prostate cancer	2.32e-05	0.00645	CrCbGaD
Eplerenone—Infection—Epirubicin—prostate cancer	2.31e-05	0.000206	CcSEcCtD
Eplerenone—Testosterone—CYP1A1—prostate cancer	2.31e-05	0.00642	CrCbGaD
Eplerenone—Cough—Doxorubicin—prostate cancer	2.3e-05	0.000205	CcSEcCtD
Eplerenone—Shock—Epirubicin—prostate cancer	2.29e-05	0.000204	CcSEcCtD
Eplerenone—Diarrhoea—Capecitabine—prostate cancer	2.29e-05	0.000204	CcSEcCtD
Eplerenone—Nervous system disorder—Epirubicin—prostate cancer	2.28e-05	0.000204	CcSEcCtD
Eplerenone—Dizziness—Docetaxel—prostate cancer	2.28e-05	0.000204	CcSEcCtD
Eplerenone—Skin disorder—Epirubicin—prostate cancer	2.26e-05	0.000202	CcSEcCtD
Eplerenone—Hyperhidrosis—Epirubicin—prostate cancer	2.25e-05	0.000201	CcSEcCtD
Eplerenone—Arthralgia—Doxorubicin—prostate cancer	2.25e-05	0.0002	CcSEcCtD
Eplerenone—Myalgia—Doxorubicin—prostate cancer	2.25e-05	0.0002	CcSEcCtD
Eplerenone—Chest pain—Doxorubicin—prostate cancer	2.25e-05	0.0002	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.23e-05	0.000199	CcSEcCtD
Eplerenone—Discomfort—Doxorubicin—prostate cancer	2.22e-05	0.000198	CcSEcCtD
Eplerenone—Dizziness—Capecitabine—prostate cancer	2.21e-05	0.000197	CcSEcCtD
Eplerenone—Vomiting—Docetaxel—prostate cancer	2.19e-05	0.000196	CcSEcCtD
Eplerenone—Rash—Docetaxel—prostate cancer	2.18e-05	0.000194	CcSEcCtD
Eplerenone—Hypotension—Epirubicin—prostate cancer	2.17e-05	0.000194	CcSEcCtD
Eplerenone—Dermatitis—Docetaxel—prostate cancer	2.17e-05	0.000194	CcSEcCtD
Eplerenone—Headache—Docetaxel—prostate cancer	2.16e-05	0.000193	CcSEcCtD
Eplerenone—Infection—Doxorubicin—prostate cancer	2.14e-05	0.000191	CcSEcCtD
Eplerenone—Asthenia—Prednisone—prostate cancer	2.13e-05	0.00019	CcSEcCtD
Eplerenone—Vomiting—Capecitabine—prostate cancer	2.12e-05	0.000189	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.12e-05	0.000189	CcSEcCtD
Eplerenone—Shock—Doxorubicin—prostate cancer	2.12e-05	0.000189	CcSEcCtD
Eplerenone—Nervous system disorder—Doxorubicin—prostate cancer	2.11e-05	0.000188	CcSEcCtD
Eplerenone—Rash—Capecitabine—prostate cancer	2.11e-05	0.000188	CcSEcCtD
Eplerenone—Pruritus—Prednisone—prostate cancer	2.11e-05	0.000188	CcSEcCtD
Eplerenone—Insomnia—Epirubicin—prostate cancer	2.1e-05	0.000188	CcSEcCtD
Eplerenone—Dermatitis—Capecitabine—prostate cancer	2.1e-05	0.000188	CcSEcCtD
Eplerenone—Headache—Capecitabine—prostate cancer	2.09e-05	0.000187	CcSEcCtD
Eplerenone—Skin disorder—Doxorubicin—prostate cancer	2.09e-05	0.000187	CcSEcCtD
Eplerenone—Hyperhidrosis—Doxorubicin—prostate cancer	2.08e-05	0.000186	CcSEcCtD
Eplerenone—Dyspnoea—Epirubicin—prostate cancer	2.07e-05	0.000185	CcSEcCtD
Eplerenone—Nausea—Docetaxel—prostate cancer	2.05e-05	0.000183	CcSEcCtD
Eplerenone—Dyspepsia—Epirubicin—prostate cancer	2.05e-05	0.000183	CcSEcCtD
Eplerenone—Diarrhoea—Prednisone—prostate cancer	2.04e-05	0.000182	CcSEcCtD
Eplerenone—Hypotension—Doxorubicin—prostate cancer	2.01e-05	0.000179	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Epirubicin—prostate cancer	2.01e-05	0.000179	CcSEcCtD
Eplerenone—Fatigue—Epirubicin—prostate cancer	2.01e-05	0.000179	CcSEcCtD
Eplerenone—Pain—Epirubicin—prostate cancer	1.99e-05	0.000178	CcSEcCtD
Eplerenone—Constipation—Epirubicin—prostate cancer	1.99e-05	0.000178	CcSEcCtD
Eplerenone—Nausea—Capecitabine—prostate cancer	1.98e-05	0.000177	CcSEcCtD
Eplerenone—Dizziness—Prednisone—prostate cancer	1.97e-05	0.000176	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.96e-05	0.000175	CcSEcCtD
Eplerenone—Insomnia—Doxorubicin—prostate cancer	1.95e-05	0.000174	CcSEcCtD
Eplerenone—Dyspnoea—Doxorubicin—prostate cancer	1.92e-05	0.000171	CcSEcCtD
Eplerenone—Feeling abnormal—Epirubicin—prostate cancer	1.92e-05	0.000171	CcSEcCtD
Eplerenone—Hydrocortisone—CYP3A4—prostate cancer	1.91e-05	0.00532	CrCbGaD
Eplerenone—Gastrointestinal pain—Epirubicin—prostate cancer	1.9e-05	0.00017	CcSEcCtD
Eplerenone—Dyspepsia—Doxorubicin—prostate cancer	1.9e-05	0.000169	CcSEcCtD
Eplerenone—Vomiting—Prednisone—prostate cancer	1.89e-05	0.000169	CcSEcCtD
Eplerenone—Rash—Prednisone—prostate cancer	1.88e-05	0.000167	CcSEcCtD
Eplerenone—Dermatitis—Prednisone—prostate cancer	1.87e-05	0.000167	CcSEcCtD
Eplerenone—Headache—Prednisone—prostate cancer	1.86e-05	0.000166	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.86e-05	0.000166	CcSEcCtD
Eplerenone—Fatigue—Doxorubicin—prostate cancer	1.86e-05	0.000166	CcSEcCtD
Eplerenone—Pain—Doxorubicin—prostate cancer	1.84e-05	0.000164	CcSEcCtD
Eplerenone—Constipation—Doxorubicin—prostate cancer	1.84e-05	0.000164	CcSEcCtD
Eplerenone—Body temperature increased—Epirubicin—prostate cancer	1.84e-05	0.000164	CcSEcCtD
Eplerenone—Abdominal pain—Epirubicin—prostate cancer	1.84e-05	0.000164	CcSEcCtD
Eplerenone—Feeling abnormal—Doxorubicin—prostate cancer	1.77e-05	0.000158	CcSEcCtD
Eplerenone—Nausea—Prednisone—prostate cancer	1.77e-05	0.000158	CcSEcCtD
Eplerenone—Gastrointestinal pain—Doxorubicin—prostate cancer	1.76e-05	0.000157	CcSEcCtD
Eplerenone—Body temperature increased—Doxorubicin—prostate cancer	1.7e-05	0.000152	CcSEcCtD
Eplerenone—Abdominal pain—Doxorubicin—prostate cancer	1.7e-05	0.000152	CcSEcCtD
Eplerenone—Asthenia—Epirubicin—prostate cancer	1.67e-05	0.000149	CcSEcCtD
Eplerenone—Pruritus—Epirubicin—prostate cancer	1.65e-05	0.000147	CcSEcCtD
Eplerenone—Diarrhoea—Epirubicin—prostate cancer	1.59e-05	0.000142	CcSEcCtD
Eplerenone—Progesterone—CYP3A4—prostate cancer	1.56e-05	0.00434	CrCbGaD
Eplerenone—Asthenia—Doxorubicin—prostate cancer	1.54e-05	0.000138	CcSEcCtD
Eplerenone—Dizziness—Epirubicin—prostate cancer	1.54e-05	0.000137	CcSEcCtD
Eplerenone—Pruritus—Doxorubicin—prostate cancer	1.52e-05	0.000136	CcSEcCtD
Eplerenone—Vomiting—Epirubicin—prostate cancer	1.48e-05	0.000132	CcSEcCtD
Eplerenone—Testosterone—CYP3A4—prostate cancer	1.47e-05	0.0041	CrCbGaD
Eplerenone—Diarrhoea—Doxorubicin—prostate cancer	1.47e-05	0.000131	CcSEcCtD
Eplerenone—Rash—Epirubicin—prostate cancer	1.47e-05	0.000131	CcSEcCtD
Eplerenone—Dermatitis—Epirubicin—prostate cancer	1.47e-05	0.000131	CcSEcCtD
Eplerenone—Headache—Epirubicin—prostate cancer	1.46e-05	0.00013	CcSEcCtD
Eplerenone—Dizziness—Doxorubicin—prostate cancer	1.42e-05	0.000127	CcSEcCtD
Eplerenone—Nausea—Epirubicin—prostate cancer	1.38e-05	0.000123	CcSEcCtD
Eplerenone—Vomiting—Doxorubicin—prostate cancer	1.37e-05	0.000122	CcSEcCtD
Eplerenone—Rash—Doxorubicin—prostate cancer	1.36e-05	0.000121	CcSEcCtD
Eplerenone—Dermatitis—Doxorubicin—prostate cancer	1.36e-05	0.000121	CcSEcCtD
Eplerenone—Headache—Doxorubicin—prostate cancer	1.35e-05	0.00012	CcSEcCtD
Eplerenone—Nausea—Doxorubicin—prostate cancer	1.28e-05	0.000114	CcSEcCtD
Eplerenone—CYP3A5—Metabolism—MTAP—prostate cancer	7.78e-06	0.000112	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTA1—prostate cancer	7.67e-06	0.00011	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PPARA—prostate cancer	7.66e-06	0.00011	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTO1—prostate cancer	7.58e-06	0.000109	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HSD3B2—prostate cancer	7.58e-06	0.000109	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NAT2—prostate cancer	7.58e-06	0.000109	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SULT1E1—prostate cancer	7.58e-06	0.000109	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SRD5A1—prostate cancer	7.58e-06	0.000109	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTM1—prostate cancer	7.36e-06	0.000106	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PLCB2—prostate cancer	7.27e-06	0.000104	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—LRP2—prostate cancer	7.27e-06	0.000104	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP2C18—prostate cancer	7.27e-06	0.000104	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	7.26e-06	0.000104	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ACSL4—prostate cancer	7.23e-06	0.000104	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HSD17B3—prostate cancer	7.23e-06	0.000104	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CAV1—prostate cancer	7.2e-06	0.000103	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—P4HB—prostate cancer	7.13e-06	0.000102	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	6.98e-06	0.0001	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC22A1—prostate cancer	6.93e-06	9.95e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ARG2—prostate cancer	6.93e-06	9.95e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PHGDH—prostate cancer	6.93e-06	9.95e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—UMPS—prostate cancer	6.93e-06	9.95e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HAO1—prostate cancer	6.88e-06	9.88e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	6.88e-06	9.87e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.88e-06	9.86e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—LDHB—prostate cancer	6.8e-06	9.75e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SULT2A1—prostate cancer	6.76e-06	9.69e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MED12—prostate cancer	6.65e-06	9.54e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GNG5—prostate cancer	6.6e-06	9.46e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CG—prostate cancer	6.56e-06	9.41e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PDHA1—prostate cancer	6.45e-06	9.25e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TCN2—prostate cancer	6.45e-06	9.25e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTA3—prostate cancer	6.45e-06	9.25e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—UCP3—prostate cancer	6.45e-06	9.25e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NCOA3—prostate cancer	6.35e-06	9.11e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—INS—prostate cancer	6.21e-06	8.9e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC22A3—prostate cancer	6.15e-06	8.82e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HSD3B1—prostate cancer	6.15e-06	8.82e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CREBBP—prostate cancer	6.08e-06	8.72e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HPGDS—prostate cancer	6.06e-06	8.69e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP2C19—prostate cancer	6.02e-06	8.64e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TBXAS1—prostate cancer	5.89e-06	8.46e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTA4—prostate cancer	5.89e-06	8.46e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTT1—prostate cancer	5.88e-06	8.43e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ACHE—prostate cancer	5.88e-06	8.43e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP2A6—prostate cancer	5.81e-06	8.34e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CD—prostate cancer	5.76e-06	8.27e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTA2—prostate cancer	5.74e-06	8.24e-05	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MYC—prostate cancer	5.67e-06	8.14e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SULT1A1—prostate cancer	5.67e-06	8.14e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ABCG5—prostate cancer	5.67e-06	8.14e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKR1C3—prostate cancer	5.65e-06	8.11e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PRKACB—prostate cancer	5.62e-06	8.07e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PSAT1—prostate cancer	5.61e-06	8.05e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CSAD—prostate cancer	5.61e-06	8.05e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ADI1—prostate cancer	5.61e-06	8.05e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CBR1—prostate cancer	5.61e-06	8.05e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TST—prostate cancer	5.61e-06	8.05e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GRHL1—prostate cancer	5.61e-06	8.05e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP17A1—prostate cancer	5.56e-06	7.98e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTA1—prostate cancer	5.54e-06	7.95e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTO1—prostate cancer	5.48e-06	7.86e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HSD3B2—prostate cancer	5.48e-06	7.86e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NAT2—prostate cancer	5.48e-06	7.86e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NOS3—prostate cancer	5.44e-06	7.81e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NCOA2—prostate cancer	5.3e-06	7.61e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PLCB2—prostate cancer	5.25e-06	7.54e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—LRP2—prostate cancer	5.25e-06	7.54e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2C18—prostate cancer	5.25e-06	7.54e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GRHPR—prostate cancer	5.22e-06	7.48e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CKMT2—prostate cancer	5.22e-06	7.48e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—UGT2B15—prostate cancer	5.22e-06	7.48e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—UGT2B17—prostate cancer	5.22e-06	7.48e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—P4HB—prostate cancer	5.15e-06	7.39e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC5A5—prostate cancer	5.06e-06	7.26e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CB—prostate cancer	5.02e-06	7.21e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC22A1—prostate cancer	5.01e-06	7.19e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTGS2—prostate cancer	4.98e-06	7.14e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP2E1—prostate cancer	4.94e-06	7.09e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SULT2B1—prostate cancer	4.9e-06	7.04e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTM3—prostate cancer	4.9e-06	7.04e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PGAM2—prostate cancer	4.9e-06	7.04e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MBTPS1—prostate cancer	4.9e-06	7.04e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NAGLU—prostate cancer	4.9e-06	7.04e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—RFK—prostate cancer	4.9e-06	7.04e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AOX1—prostate cancer	4.9e-06	7.04e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NQO1—prostate cancer	4.89e-06	7.01e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SULT2A1—prostate cancer	4.88e-06	7.01e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—TH—prostate cancer	4.81e-06	6.91e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MED12—prostate cancer	4.81e-06	6.89e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GNG5—prostate cancer	4.77e-06	6.84e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP3A4—prostate cancer	4.76e-06	6.83e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP1B1—prostate cancer	4.68e-06	6.72e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—DEGS1—prostate cancer	4.65e-06	6.67e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SRD5A2—prostate cancer	4.65e-06	6.67e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AMACR—prostate cancer	4.65e-06	6.67e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP3A43—prostate cancer	4.65e-06	6.67e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NAT1—prostate cancer	4.65e-06	6.67e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NCOA3—prostate cancer	4.59e-06	6.59e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GGT1—prostate cancer	4.54e-06	6.51e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NCOA1—prostate cancer	4.47e-06	6.41e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HSD17B1—prostate cancer	4.44e-06	6.36e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP19A1—prostate cancer	4.4e-06	6.32e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HPGDS—prostate cancer	4.38e-06	6.28e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2C19—prostate cancer	4.35e-06	6.25e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTEN—prostate cancer	4.34e-06	6.23e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—RXRA—prostate cancer	4.25e-06	6.1e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ACHE—prostate cancer	4.25e-06	6.1e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTT1—prostate cancer	4.25e-06	6.1e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2A6—prostate cancer	4.2e-06	6.03e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—EP300—prostate cancer	4.14e-06	5.94e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—COMT—prostate cancer	4.09e-06	5.87e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKR1C3—prostate cancer	4.09e-06	5.86e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTP1—prostate cancer	4.07e-06	5.85e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PRKACB—prostate cancer	4.06e-06	5.83e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP17A1—prostate cancer	4.02e-06	5.77e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ITPR1—prostate cancer	4.01e-06	5.75e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HPGD—prostate cancer	3.95e-06	5.67e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.95e-06	5.67e-05	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—AKT1—prostate cancer	3.94e-06	5.65e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NCOA2—prostate cancer	3.83e-06	5.5e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—TYMS—prostate cancer	3.79e-06	5.43e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTM1—prostate cancer	3.74e-06	5.37e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.72e-06	5.33e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—LPL—prostate cancer	3.68e-06	5.27e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC5A5—prostate cancer	3.66e-06	5.25e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.62e-06	5.19e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MTAP—prostate cancer	3.62e-06	5.19e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2E1—prostate cancer	3.57e-06	5.12e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP1A1—prostate cancer	3.55e-06	5.09e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NQO1—prostate cancer	3.53e-06	5.07e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.52e-06	5.06e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.52e-06	5.06e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ERCC2—prostate cancer	3.52e-06	5.05e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TH—prostate cancer	3.48e-06	4.99e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP3A4—prostate cancer	3.44e-06	4.94e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP1B1—prostate cancer	3.39e-06	4.86e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ACSL4—prostate cancer	3.36e-06	4.82e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.36e-06	4.82e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MTHFR—prostate cancer	3.31e-06	4.75e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GGT1—prostate cancer	3.28e-06	4.7e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PPARA—prostate cancer	3.25e-06	4.66e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NCOA1—prostate cancer	3.23e-06	4.63e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ARG2—prostate cancer	3.22e-06	4.62e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PHGDH—prostate cancer	3.22e-06	4.62e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—UMPS—prostate cancer	3.22e-06	4.62e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP19A1—prostate cancer	3.18e-06	4.57e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—LDHB—prostate cancer	3.16e-06	4.53e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.1e-06	4.45e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—RXRA—prostate cancer	3.07e-06	4.41e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CA—prostate cancer	3.06e-06	4.39e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CAV1—prostate cancer	3.05e-06	4.38e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PDHA1—prostate cancer	3e-06	4.3e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—UCP3—prostate cancer	3e-06	4.3e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TCN2—prostate cancer	3e-06	4.3e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTA3—prostate cancer	3e-06	4.3e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—COMT—prostate cancer	2.96e-06	4.25e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTP1—prostate cancer	2.95e-06	4.23e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ITPR1—prostate cancer	2.9e-06	4.16e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.86e-06	4.1e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.86e-06	4.1e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CG—prostate cancer	2.78e-06	3.99e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTA4—prostate cancer	2.74e-06	3.93e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.74e-06	3.93e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TYMS—prostate cancer	2.74e-06	3.93e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTM1—prostate cancer	2.71e-06	3.88e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTA2—prostate cancer	2.67e-06	3.83e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—LPL—prostate cancer	2.66e-06	3.81e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ABCG5—prostate cancer	2.64e-06	3.78e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.64e-06	3.78e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—INS—prostate cancer	2.63e-06	3.78e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CREBBP—prostate cancer	2.58e-06	3.7e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTA1—prostate cancer	2.58e-06	3.7e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.57e-06	3.68e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.55e-06	3.65e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NAT2—prostate cancer	2.55e-06	3.65e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTO1—prostate cancer	2.55e-06	3.65e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ERCC2—prostate cancer	2.54e-06	3.65e-05	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—AKT1—prostate cancer	2.5e-06	3.59e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CD—prostate cancer	2.44e-06	3.51e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PLCB2—prostate cancer	2.44e-06	3.5e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—LRP2—prostate cancer	2.44e-06	3.5e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.44e-06	3.5e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—P4HB—prostate cancer	2.4e-06	3.44e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MTHFR—prostate cancer	2.39e-06	3.43e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PPARA—prostate cancer	2.35e-06	3.37e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.33e-06	3.34e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NOS3—prostate cancer	2.31e-06	3.31e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.27e-06	3.26e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MED12—prostate cancer	2.23e-06	3.2e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GNG5—prostate cancer	2.22e-06	3.18e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CAV1—prostate cancer	2.21e-06	3.17e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NCOA3—prostate cancer	2.14e-06	3.06e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CB—prostate cancer	2.13e-06	3.06e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTGS2—prostate cancer	2.11e-06	3.03e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HPGDS—prostate cancer	2.04e-06	2.92e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.02e-06	2.9e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CG—prostate cancer	2.01e-06	2.88e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.98e-06	2.83e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ACHE—prostate cancer	1.98e-06	2.83e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.95e-06	2.8e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—INS—prostate cancer	1.9e-06	2.73e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.9e-06	2.73e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.89e-06	2.71e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.87e-06	2.68e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CREBBP—prostate cancer	1.86e-06	2.67e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTEN—prostate cancer	1.84e-06	2.64e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.78e-06	2.56e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.77e-06	2.53e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—EP300—prostate cancer	1.76e-06	2.52e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.7e-06	2.44e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NOS3—prostate cancer	1.67e-06	2.39e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.66e-06	2.38e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NQO1—prostate cancer	1.64e-06	2.36e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TH—prostate cancer	1.62e-06	2.32e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.57e-06	2.26e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.54e-06	2.21e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTGS2—prostate cancer	1.53e-06	2.19e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GGT1—prostate cancer	1.52e-06	2.19e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.5e-06	2.15e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.48e-06	2.12e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—RXRA—prostate cancer	1.43e-06	2.05e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—COMT—prostate cancer	1.38e-06	1.97e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.37e-06	1.96e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.35e-06	1.93e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTEN—prostate cancer	1.33e-06	1.91e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.3e-06	1.86e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TYMS—prostate cancer	1.27e-06	1.83e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—EP300—prostate cancer	1.27e-06	1.82e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.26e-06	1.81e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—LPL—prostate cancer	1.24e-06	1.77e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.19e-06	1.71e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.18e-06	1.7e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.11e-06	1.6e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PPARA—prostate cancer	1.09e-06	1.57e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKT1—prostate cancer	1.06e-06	1.52e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CAV1—prostate cancer	1.03e-06	1.47e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CA—prostate cancer	9.39e-07	1.35e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.34e-07	1.34e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—INS—prostate cancer	8.84e-07	1.27e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CREBBP—prostate cancer	8.66e-07	1.24e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.21e-07	1.18e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NOS3—prostate cancer	7.76e-07	1.11e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKT1—prostate cancer	7.67e-07	1.1e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.16e-07	1.03e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTGS2—prostate cancer	7.09e-07	1.02e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTEN—prostate cancer	6.19e-07	8.88e-06	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—EP300—prostate cancer	5.9e-07	8.46e-06	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.36e-07	6.26e-06	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKT1—prostate cancer	3.57e-07	5.11e-06	CbGpPWpGaD
